Skip to main content

Study M478

Study name

Lian B 2018

Title

Mechanisms of ketamine on mice hippocampi shown by gas chromatography-mass spectrometry-based metabolomic analysis

Overall design

In the present study, we used a gas chromatography-mass spectrometry-based metabolomics method to evaluate the effects of ketamine on mice hippocampi. Multivariate statistical analysis and ingenuity pathway analysis were then used to identify and explore the potential mechanisms and biofunction of ketamine. Mice were assigned randomly to each of the following four treatment groups (n = 10 each): (1) control group: treated with saline at a single dose of 1 ml/kg, intraperitoneally; (2) ketamine group: treated with ketamine at a single dose of 10 mg/kg, intraperitoneally; (3) NBQX group: treated with 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) at a single dose of 10 mg/kg, intraperitoneally; and (4) ketamine + NBQX group: pretreated with NBQX 30 min before the treatment of ketamine, both at a single dose of 10 mg/kg, intraperitoneally.

Study Type

Type3;

Data available

Unavailable

Organism

Mouse; C57BL/6J mouse;

Categories of depression

Healthy individuals; Healthy individuals; Healthy individuals;

Criteria for depression

Forced swimming test

Sample size

40

Tissue

Central; Brain; Hippocampus;

Platform

MS-based; GC-MS: Agilent 7980 GC system (Agilent Technologies Inc., USA);

PMID

29742621

DOI

10.1097/WNR.0000000000001020

Citation

Lian B, Xia J, Yang X, et al. Mechanisms of ketamine on mice hippocampi shown by gas chromatography-mass spectrometry-based metabolomic analysis. Neuroreport. 2018;29(9):704-11.

Metabolite

myo-Inositol;

Gamma-Aminobutyric acid;

Glycine;

L-Alanine;

L-Glutamine;

L-Aspartic acid;

Urea;

Ascorbic acid;

Creatine;

Inosine;

L-Malic acid;

Aminomalonic acid;

Phosphate;

Galactinol;